Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
14.38
+0.26 (1.84%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Vor Biopharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 779 | 506 | 138 | 153 | 437 | 433 | |
| Market Cap Growth | 791.56% | 266.35% | -9.38% | -65.05% | 0.75% | - | |
| Enterprise Value | 327 | 339 | 108 | 29 | 341 | 225 | |
| Last Close Price | 14.38 | 13.08 | 22.20 | 45.00 | 133.00 | 232.40 | |
| PB Ratio | - | -3.08 | 1.43 | 1.01 | 1.74 | 2.00 | |
| P/TBV Ratio | - | - | 1.43 | 1.01 | 1.74 | 2.00 | |
| Debt / Equity Ratio | -0.02 | -0.02 | 0.33 | 0.24 | 0.16 | 0.08 | |
| Net Debt / Equity Ratio | 2.75 | 2.75 | -0.62 | -0.67 | -0.76 | -0.88 | |
| Net Debt / EBITDA Ratio | 1.33 | 1.33 | 0.51 | 0.83 | 2.11 | 2.80 | |
| Net Debt / FCF Ratio | 3.15 | 3.15 | 0.60 | 1.00 | 2.04 | 2.59 | |
| Quick Ratio | 18.09 | 18.09 | 4.94 | 8.81 | 17.55 | 20.43 | |
| Current Ratio | 18.20 | 18.20 | 5.19 | 9.04 | 18.06 | 21.12 | |
| Return on Equity (ROE) | - | - | -94.52% | -58.74% | -39.45% | -52.09% | |
| Return on Assets (ROA) | -70.41% | -70.41% | -44.42% | -31.67% | -21.55% | -27.09% | |
| Return on Capital Employed (ROCE) | -77.90% | -77.90% | -97.50% | -69.00% | -32.60% | -29.70% | |
| Earnings Yield | -89.32% | -137.42% | -84.57% | -77.25% | -21.09% | -15.90% | |
| FCF Yield | -18.44% | -28.36% | -72.25% | -66.44% | -21.44% | -16.86% | |
| Buyback Yield / Dilution | -187.35% | -187.35% | -2.26% | -69.88% | -18.30% | -15547.86% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.